Ecchymosis in Critical Coronavirus Disease 2019 (COVID-19) Patient in Tangerang, Indonesia: a Case Report
Overview
Authors
Affiliations
We have read with great interest the articles regarding cutaneous manifestations in Coronavirus Disease 2019 (COVID-19) infection. Studies showed 20.4% of COVID-19 patients developed cutaneous manifestations. COVID-19 causes vascular endothelial injury, vasculitis and prothrombotic state which might be the underlying cause of hemorrhagic cutaneous manifestations, disseminated intravascular coagulation (DIC), and multiple organ failures. To date, hemorrhagic cutaneous manifestations reported are chilblain-like lesion, purpura to ecchymosis, livedo reticularis, and dry gangrene. We present a case of ecchymosis in COVID-19-positive ICU hospitalized patient.
Cutaneous Manifestation in COVID-19: A Lesson Over 2 Years Into the Pandemic.
Danarti R, Limantara N, Rini D, Budiarso A, Febriana S, Soebono H Clin Med Res. 2023; 21(1):36-45.
PMID: 37130789 PMC: 10153677. DOI: 10.3121/cmr.2023.1598.
COVID-19 and New Onset IgA Vasculitis: A Systematic Review of Case Reports.
Messova A, Pivina L, Muzdubayeva Z, Sanbayev D, Urazalina Z, Adams A J Emerg Nurs. 2022; 48(4):348-365.
PMID: 35691763 PMC: 9098918. DOI: 10.1016/j.jen.2022.05.002.
Time of Onset of Selected Skin Lesions Associated with COVID-19: A Systematic Review.
Gisondi P, Di Leo S, Bellinato F, Cazzaniga S, Piaserico S, Naldi L Dermatol Ther (Heidelb). 2021; 11(3):695-705.
PMID: 33811315 PMC: 8018690. DOI: 10.1007/s13555-021-00526-8.